Message #14 From:
Stock News Bot Date: January 4, 2006 03:00:00 AM
PBME News Pacific Biometrics Appoints Curtis J. Scheel to the Board of Directors
SEATTLE--(BUSINESS WIRE)--Jan. 4, 2006--Pacific Biometrics, Inc. (PBI; OTCBB: PBME) announces the appointment of Curtis J. Scheel as a director to the company serving on the audit and compensation committees. This appointment, effective January 1, 2006, will bring the total number of board members to five.
Mr. Scheel has over twenty years of experience in finance and currently serves as the Chief Operating Officer of Ritz Camera Centers, the largest specialty retailer of photographic products and services in the United States. Mr. Scheel began his career in 1982 in Commercial Banking at First Wisconsin National Bank and continued in commercial banking for over seven years. In subsequent years, Mr. Scheel held several senior financial management positions, including Vice President and Treasurer for Microage, Inc. and Vice President and Director of Marketing for the Technology Division of Deutsche Financial Services Corp. In 1999 Mr. Scheel joined Cameraworld.com, Inc., serving initially as Vice President & Chief Financial Officer and later as President and a member of the Board of Directors. Mr. Scheel graduated from the University of Wisconsin-Madison and holds a Masters of Business Administration degree.
"This is an exciting time for Mr. Scheel to join our Board," commented Ron Helm, CEO. "During 2005 we significantly strengthened our services pipeline and explored a variety of new opportunities for our subsidiary PBI Tech." Mr. Helm concluded, "Mr. Scheel's diversified experience in finance and corporate management for publicly traded companies will contribute significant depth to our Board."
Established in 1989, PBI provides specialized central laboratory and contract research services to support pharmaceutical and diagnostic manufacturers conducting human clinical trial research. The company provides expert services in the areas of cardiovascular disease, diabetes, osteoporosis, arthritis, and nutrition. The PBI laboratory is accredited by the College of American Pathologists, and through its non-profit affiliate Pacific Biometrics Research Foundation, is one of only three U.S.-based members of the Centers for Disease Control (CDC) Cholesterol Reference Method Laboratory Network. PBI's clients include many of the world's largest pharmaceutical, biotech, and diagnostic companies.
Pacific Biometrics also owns several patented and patent-pending technologies, including monitoring devices for glucose and changes in bone turnover, an advanced, proprietary, isothermal DNA amplification technology, and a gene-based cell viability technology to distinguish live from dead cells in a broad range of diagnostic applications.
For more information about Pacific Biometrics, visit the company's web site at www.pacbio.com.
